OS2966 DRAMATICALLY ENHANCES PRECLINICAL EFFICACY OF ONCOLYTIC VIRUS THERAPY

被引：0
|
作者：
Carbonell, Shawn [1 ]
Yoo, Ji Young [2 ]
Nallanagulagari, Tejaswini [2 ,3 ]
Jaime-Ramirez, Alena Cristina [2 ]
Bolyard, Chelsea [2 ]
Lee, Tae Jin [4 ]
Zhang, Jianying [5 ]
Croce, Carlo [4 ]
Wu, Eric [1 ]
Aghi, Manish [6 ]
Kaur, Balveen [2 ]
机构：
[1] OncoSynergy Inc, San Francisco, CA USA
[2] Ohio State Univ, Coll Med, Dept Neurol Surg, Dardinger Lab Neurooncol & Neurosci, Columbus, OH 43210 USA
[3] Ohio State Univ, Biochem & Microbiol Majors, Columbus, OH 43210 USA
[4] Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[5] Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA
[6] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-33
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [21] PD-L1 enhances the efficacy of the oncolytic virus VSVΔ51
    Hodgins, Jonathan
    Park, Maria M.
    Bell, John C.
    Bourgeois-Daigneault, Marie-Claude
    Ardolino, Michele
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [22] TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy
    Valenzuela-Cardenas, Miriam
    Gowan, Cody
    Dryja, Parker
    Bartee, Mee Y.
    Bartee, Eric
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (05)
  • [23] Enhancing the efficacy of oncolytic virus immunotherapy using eicosapentaenoic acid in preclinical cancer models
    Khumo, Nametso Koobotse
    Volpato, Milene
    Errington-Mais, Fiona
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [24] Hormonal milieu enhances the efficacy of oncolytic herpes viral therapy in prostate cancer
    Bhargava, A
    Stiles, BM
    Mullerad, M
    Gusani, NJ
    Adusumilli, P
    Kim, TH
    Fong, YM
    MOLECULAR THERAPY, 2003, 7 (05) : S368 - S368
  • [25] Preclinical assessment of efficacy and safety of novel oncolytic adenovirus for therapy of disseminated lung cancer
    Atasheva, Svetlana
    Yao, Jia
    Young, Cedrick
    Di Paolo, Nelson C.
    Wyche, Henry
    Shayakhmetov, Dmitry M.
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Bacterial-Mediated Knockdown of Tumor Resistance to an Oncolytic Virus Enhances Therapy
    Cronin, Michelle
    Le Boeuf, Fabrice
    Murphy, Carola
    Roy, Dominic G.
    Falls, Theresa
    Bell, John C.
    Tangney, Mark
    MOLECULAR THERAPY, 2014, 22 (06) : 1188 - 1197
  • [27] NOVEL ANGIOGENESIS INHIBITOR TETRATHIOMOLYBDATE ENHANCES THE TUMOR CELL KILLING EFFICACY OF ONCOLYTIC VIRUS
    Yoo, Ji Young
    Pradarelli, Jason
    Kaka, Azeem
    Alvarez-Breckenridge, Christopher
    Pan, Quintin
    Teknos, Ted
    Chiocca, E. A.
    Kaur, Balveen
    NEURO-ONCOLOGY, 2010, 12 : 94 - 94
  • [28] Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors
    Nagano, Satoshi
    Perentes, Jean Yannis
    Jain, Rakesh K.
    Boucher, Yves
    CANCER RESEARCH, 2008, 68 (10) : 3795 - 3802
  • [29] Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
    Ma, Jing
    Jin, Chuan
    Cancer, Matko
    Wang, Hai
    Ramachandran, Mohanraj
    Yu, Di
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 21 : 356 - 366
  • [30] HISTONE DEACETYLASE INHIBITOR ENHANCES ONCOLYTIC HERPES SIMPLEX VIRUS THERAPY FOR MALIGNANT MENINGIOMA
    Hua, Lingyang
    Gartner, Alessandra
    Kiyokawa, Juri
    Rabkin, Samuel
    Martuza, Robert
    Wakimoto, Hiroaki
    NEURO-ONCOLOGY, 2018, 20 : 89 - 89
12345